Designing better ways to deliver drugs
Graduate student and MathWorks fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.
Evidence that gamma rhythm stimulation can treat neurological disorders is emerging
Researchers survey a broadening landscape of studies showing what’s known, and what remains to be found, about the therapeutic potential of noninvasive sensory, electrical, or magnetic stimulation of gamma brain rhythms.
Artificial intelligence model “learns” from patient data to make cancer treatment less toxic
Machine-learning system determines the fewest, smallest doses that could still shrink brain tumors.
Sensor could help doctors select effective cancer therapy
Hydrogen peroxide-sensing molecule reveals whether chemotherapy drugs are having their intended effects.
Scientists sharpen the edges of cancer chemotherapy
Whitehead team deploys CRISPR tools to better understand and uncover ways of improving methotrexate, a popular chemotherapy drug.
M+Visión Fellow Carlos Castro named one of Spain’s top young innovators
Postdoc researcher recognized for leukemia management innovation.
Real-time data for cancer therapy
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
How to identify drugs that work best for each patient
Implantable device could allow doctors to test cancer drugs in patients before prescribing chemotherapy.
Better chemotherapy through targeted delivery
New approach could kill tumor cells in the brain more effectively and avoid side effects.
Advancing medicine, layer by layer
Studies by graduate students Stephen Morton and Nisarg Shah show progress toward better cancer treatment and bone replacement.
Faculty highlight: Paula Hammond
Engineering tiny paths to cancer treatment, bone regrowth, and wound healing, Paula Hammond serves as an exemplary researcher-educator within the MIT community.
Targeting cancer with a triple threat
MIT chemists design nanoparticles that can deliver three cancer drugs at a time.
Biologists ID new cancer weakness
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.
Resistance is futile
Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin.
Study reveals how melanoma evades chemotherapy
Drugs that block nitric oxide could weaken cancer cells’ resistance, researchers say.